Roundtable Discussion; The Future of Mineral Sands. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksEast Imperial Regulatory News (EISB)

  • This share is currently suspended. It was suspended at a price of 0.28

Share Price Information for East Imperial (EISB)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 0.28
Bid: 0.00
Ask: 0.00
Change: 0.00 (0.00%)
Spread: 0.00 (0.00%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 0.28
EISB Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Notice of GM and Capital Reorganisation

2 Feb 2024 12:19

RNS Number : 8983B
East Imperial PLC
02 February 2024
 

The information contained within this announcement is deemed by the Company to constitute inside information pursuant to Article 7 of EU Regulation 596/2014 as it forms part of UK domestic law by virtue of the European Union (Withdrawal) Act 2018 as amended.

2 February 2024

East Imperial plc

("East Imperial" or the "Company")

 

Notice of General Meeting

Capital Reorganisation

East Imperial, the global purveyor of super-premium beverages, announces that further to its announcement on 24 January 2024, it will today post to shareholders a circular containing a notice of general meeting ("GM") to renew authorities to allot new ordinary shares, as well as to change the nominal value of ordinary shares.

Notice of GM

As announced on 24 January 2024, the Company raised approximately £325,000 by way of a placing of 29,545,454 ordinary shares ("Placing Shares") with one investor ("Placing"). Establishing the Company's US base and distributors has taken longer than planned, and with sales in China growing slower than expected, the Company's cash flow break-even point is now expected to occur later than anticipated. Therefore, the Company requires additional working capital to finance operations during 2024. The net proceeds of the Placing have provided the Company with a cash runway until April 2024. 

Following the allotment of the Placing Shares, the Company's remaining authority to allot further shares on a non pre-emptive basis has been reduced to 4,271,650 ordinary shares of one penny each ("Existing Ordinary Shares"), which the Board considers insufficient in light of the Company's future working capital requirements. As indicated in the announcement of 24 January 2024, the Board has therefore decided to convene a GM to obtain additional authorities to allot shares on a non pre-emptive basis in order to provide the Company with the ability to issue shares for working capital for the period after April 2024. In addition, subject to shareholder approval, the Board proposes to reduce the nominal value of ordinary shares ("Capital Reorganisation") to provide the Board with the flexibility it considers necessary to facilitate future fundraises by the Company, details of which are set out further below.

A circular, which includes notice of the GM, will be sent to shareholders today to convene a general meeting at 11:00 a.m. on 19 February 2024 at the offices of Fasken Martineau LLP, 100 Liverpool Street, London, EC2M 2AT. The purpose of the GM is to: (i) seek shareholder approval to a Capital Reorganisation, which will also require amendments to the Company's articles of association; and (ii) obtain further authorities to enable the Board to allot shares on a non pre-emptive basis.

The Directors of the Company consider that all the resolutions to be considered at the GM are in the best interests of the Company and its members as a whole. The Directors unanimously recommend that shareholders vote in favour of all the resolutions as they intend to do in respect of their own beneficial holdings.

If the resolutions are not approved by shareholders, the Company's ability to raise additional working capital through equity will be restricted and therefore the performance, financial position and prospects of the Company could be adversely affected and alternative funding solutions will need to be sought.

Capital Reorganisation

As the Company is not permitted by law to issue shares at an issue price which is below their nominal value, the Company's ability to raise funds from investors is limited due to the proximity of the mid-market price of the shares to their nominal value. Whilst the Board's objective is to achieve the highest possible issue price for the Company when issuing shares, it is cognisant that, given current market conditions, the Company may be unable to issue shares at a sufficient discount to their market price in order to attract further equity investment into the business.

In order to enable the Company to issue shares at an issue price which exceeds their nominal value, shareholder approval is being sought to complete a Capital Reorganisation.

The Capital Reorganisation will involve:

· each of the existing ordinary shares of one penny each will be subdivided into and reclassified as one New Ordinary Share (defined below) and one Deferred Share (defined below);

· each New Ordinary Share will be an ordinary share in the capital of the Company with a nominal value of £0.001 (0.1 pence); and

· each Deferred Share will be a deferred share in the capital of the Company with a nominal value of £0.009 (0.9 pence).

Subject to the passing of the relevant resolutions at the AGM, the Capital Reorganisation will take effect at the close of business on the date of the GM ("Record Date").

As a consequence of, and immediately following, the Capital Reorganisation becoming effective each Shareholder's holding of New Ordinary Shares will be the same as the number of Existing Ordinary Shares held by them on the Record Date. Each shareholder's proportionate interest in the Company's issued ordinary share capital will, and thus the aggregate value of their holding should, remain unchanged as a result of the Capital Reorganisation.

The New Ordinary Shares will have the same rights as those currently accruing to the Existing Ordinary Shares in issue under the articles of association of the Company, including those relating to voting and entitlement to dividends.

The Deferred Shares created will be effectively valueless as they will not carry any rights to vote or dividend rights. The Deferred Shares will not be traded on the London Stock Exchange's ("LSE") Main Market for listed securities or listed and will not be transferable without the prior written consent of the Board. No share certificates will be issued in respect of the Deferred Shares, nor will CREST accounts of Shareholders be credited in respect of any entitlement to Deferred Shares.

The intention is that Deferred Shares would be cancelled in due course following a court approved reduction of capital or other means, if available.

Admission

Application has been made to the UK Financial Conduct Authority ("FCA") and the LSE for the New Ordinary Shares to be admitted to the standard segment of the FCA Official List and to trading on the LSE's Main Market for listed securities ("Admission"). Admission is expected to occur at 8.00 a.m. on or around 20 February 2024.

Total Voting Rights

Following Admission of the New Ordinary Shares, assuming no other issue of New Ordinary Shares takes place (such as from the exercise of any convertible securities) prior to the General Meeting, the total issued share capital of the Company with voting rights will comprise 367,716,497 New Ordinary Shares.

The Company does not hold any Ordinary Shares in treasury. Therefore, following Admission of the New Ordinary Shares, the above figure of 367,716,497 New Ordinary Shares may be used by Shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, the share capital of the Company under the FCA's Disclosure, Guidance and Transparency Rules.

 

EXPECTED TIMETABLE OF PRINCIPAL EVENTS

Publication of circular and Notice of GM

2 February 2024

Latest time and date for voting by proxy for GM

11.00 a.m. on 15 February 2024

General Meeting

19 February 2024

Announcement of the result of the GM

19 February 2024

Record Date and final date and time for trading in Existing Ordinary Shares

6.00 p.m. on 19 February 2024

Expected date of Admission of the New Ordinary Shares arising from the Capital Reorganisation

20 February 2024

 

KEY STATISTICS RELATING TO THE CAPITAL REORGANISATION

Prior to the Capital Reorganisation

Number of Existing Ordinary Shares

367,716,497

Post Capital Reorganisation

Number of New Ordinary Shares

367,716,497

Number of Deferred Shares

367,716,497

ISIN code for the New Ordinary Shares

GB00BMZ1ND56

 

 

For further information, please contact:

East Imperial plc

Anthony Burt

Robin Stevens

 

investors@eastimperial.com

Allenby Capital Limited (Broker)

Guy McDougall / Matt Butlin (Sales and Corporate Broking)

Jeremy Porter / Piers Shimwell (Corporate Finance)

+44 (0)20 3328 5656

 

 

About East Imperial

Founded in New Zealand and Singapore in 2012, East Imperial produces a range of super-premium mixers that sell throughout APAC, the US and EMEA. Guided by a clear strategy to capitalise on the growing demand for premiumisation across the beverage industry, East Imperial has sold over 32 million bottles in over 20 countries since its founding, with popular products including Old World Tonic Water, Grapefruit Tonic Water, Yuzu Tonic Water and Mombasa Ginger Beer. In 2023, East Imperial won 9 medals at the coveted Tonic & Mixers Masters Competition in London. The Company was founded on the philosophy of creating exquisite products defined by heritage, tradition, and authenticity. All products are made from high quality, all-natural ingredients, reflecting East Imperial's commitment to providing a sustainable product and minimising environmental impacts at every stage of the manufacturing process. For more information about East Imperial and its premium mixers. Visit https://www.eastimperial.com.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
NOGBDGDDIBGDGSD
12
Date   Source Headline
15th Apr 20247:57 amRNSSuspension of Share Trading
15th Apr 20247:30 amRNSSuspension - East Imperial plc
12th Apr 20244:42 pmRNSCorporate Update
11th Apr 20243:27 pmRNSUpdate re. potential funding sources
11th Apr 20247:00 amRNSResignation of Director
6th Mar 20247:00 amRNSInterview with Chief Executive Officer, Tony Burt
29th Feb 20249:32 amRNSHolding(s) in Company
26th Feb 20247:00 amRNSDirectorsTalk Interview
22nd Feb 20247:00 amRNSYear-End Trading Update
19th Feb 20246:07 pmRNSResult of General Meeting
13th Feb 20247:00 amRNSContinued Global Account Wins in 2024
5th Feb 20247:00 amRNSPartnership with Galaxy Entertainment Group
2nd Feb 202412:19 pmRNSNotice of GM and Capital Reorganisation
2nd Feb 20247:00 amRNSManagement and Board changes
31st Jan 20245:00 pmRNSTotal Voting Rights
31st Jan 20247:00 amRNSHolding(s) in Company
24th Jan 20247:50 amRNSProposed Placing to raise approximately £325,000
3rd Jan 20247:00 amRNSNew Zealand Trading Update
13th Dec 20237:16 amRNSHolding(s) in Company
8th Dec 20237:00 amRNSAppointment of Allenby Capital as Broker
13th Nov 20238:02 amRNSDirectorship Changes
7th Nov 20237:05 amRNSDirectorsTalk Interview
7th Nov 20237:00 amRNSSecond Completion - Secured Convertible Loan Notes
29th Sep 20237:10 amRNSInterim Results
29th Sep 20237:00 amRNSPartnership Agreement
6th Sep 20238:13 amRNSDirectorship Changes
22nd Aug 20237:14 amRNSAppointment of Key US Sales Resource
15th Aug 20237:40 amRNSHolding(s) in Company
14th Aug 202312:54 pmRNSFirst Completion - Secured Convertible Loan Notes
14th Aug 20237:00 amRNSHolding(s) in Company
10th Aug 20238:46 amRNSHolding(s) in Company
4th Aug 202311:18 amRNSResult of General Meeting
28th Jul 20237:00 amRNSAir New Zealand Partnership
19th Jul 202312:25 pmRNSNotice of GM
17th Jul 20237:00 amRNSFunding Update – issue of £2.2m Convertible Loan
30th Jun 202310:13 amRNSResult of AGM
6th Jun 20237:55 amRNSPosting of Annual Report and Notice of AGM
2nd May 20237:00 amRNSAudited Full-Year Results
13th Apr 20237:00 amRNSBoard Change
17th Feb 202310:26 amRNSHolding(s) in Company
9th Feb 20232:05 pmRNSSecond Price Monitoring Extn
9th Feb 20232:00 pmRNSPrice Monitoring Extension
7th Feb 20237:00 amRNSPre-Close Trading Statement
13th Jan 202310:00 amRNSTR-1: Notification of Major Holdings
8th Dec 20227:00 amRNSVietnam Distribution Agreement
24th Nov 20229:06 amRNSSecond Price Monitoring Extn
24th Nov 20229:00 amRNSPrice Monitoring Extension
24th Nov 20227:00 amRNSAppointment of US Bottling Partner
17th Oct 202210:00 amRNSTR1 notification
14th Sep 202211:06 amRNSSecond Price Monitoring Extn
12

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.